Quaker Chemical (NYSE:KWR) Raised to “Buy” at StockNews.com

Quaker Chemical (NYSE:KWR) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Thursday.

Several other brokerages have also recently commented on KWR. Royal Bank of Canada reduced their price objective on shares of Quaker Chemical from $195.00 to $180.00 and set an “outperform” rating for the company in a research note on Monday, November 4th. Piper Sandler boosted their price objective on shares of Quaker Chemical from $190.00 to $200.00 and gave the company an “overweight” rating in a research note on Friday, November 8th. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Quaker Chemical from $190.00 to $182.00 and set a “buy” rating for the company in a research note on Monday, November 4th.

Quaker Chemical Stock Performance

Shares of KWR traded down $1.94 during trading hours on Thursday, hitting $155.86. The company’s stock had a trading volume of 163,398 shares, compared to its average volume of 96,040. The company has a market cap of $2.77 billion, a price-to-earnings ratio of 22.85, a PEG ratio of 1.96 and a beta of 1.38. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.54 and a quick ratio of 1.88. The business has a 50 day simple moving average of $163.34 and a two-hundred day simple moving average of $169.37. Quaker Chemical has a 52-week low of $151.31 and a 52-week high of $221.94.

Quaker Chemical (NYSE:KWR) last posted its earnings results on Thursday, October 31st. The specialty chemicals company reported $1.89 earnings per share for the quarter, missing the consensus estimate of $2.08 by ($0.19). The business had revenue of $462.27 million during the quarter, compared to analysts’ expectations of $469.17 million. Quaker Chemical had a return on equity of 10.10% and a net margin of 6.58%. Quaker Chemical’s revenue for the quarter was down 5.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.05 EPS. On average, equities analysts expect that Quaker Chemical will post 7.78 earnings per share for the current fiscal year.

Insider Transactions at Quaker Chemical

In other news, EVP Jeewat Bijlani sold 645 shares of the business’s stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of $165.98, for a total value of $107,057.10. Following the completion of the sale, the executive vice president now directly owns 4,747 shares in the company, valued at approximately $787,907.06. The trade was a 11.96 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP David Slinkman sold 1,700 shares of the business’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $167.80, for a total transaction of $285,260.00. Following the completion of the sale, the senior vice president now owns 2,825 shares of the company’s stock, valued at approximately $474,035. The trade was a 37.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.30% of the company’s stock.

Institutional Investors Weigh In On Quaker Chemical

Several institutional investors have recently added to or reduced their stakes in the company. State Street Corp boosted its position in Quaker Chemical by 3.8% during the 3rd quarter. State Street Corp now owns 554,612 shares of the specialty chemicals company’s stock valued at $93,447,000 after buying an additional 20,059 shares during the period. Royce & Associates LP boosted its position in Quaker Chemical by 5.3% during the 3rd quarter. Royce & Associates LP now owns 434,303 shares of the specialty chemicals company’s stock valued at $73,176,000 after buying an additional 21,986 shares during the period. Copeland Capital Management LLC boosted its position in Quaker Chemical by 0.7% during the 3rd quarter. Copeland Capital Management LLC now owns 388,719 shares of the specialty chemicals company’s stock valued at $65,495,000 after buying an additional 2,592 shares during the period. Dimensional Fund Advisors LP boosted its position in Quaker Chemical by 14.8% during the 2nd quarter. Dimensional Fund Advisors LP now owns 359,617 shares of the specialty chemicals company’s stock valued at $61,027,000 after buying an additional 46,240 shares during the period. Finally, Geode Capital Management LLC boosted its position in Quaker Chemical by 1.0% during the 3rd quarter. Geode Capital Management LLC now owns 312,784 shares of the specialty chemicals company’s stock valued at $52,713,000 after buying an additional 3,118 shares during the period. Hedge funds and other institutional investors own 77.46% of the company’s stock.

Quaker Chemical Company Profile

Quaker Chemical Corporation, together with its subsidiaries, develops, produces, and markets various formulated specialty chemical products for a range of heavy industrial and manufacturing applications in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals.